Why the study?
Interracial differences in the distribution and prognostic value of conventional Society of Thoracic Surgeons score on long-term mortality after TAVR are uncertain.
Does the prognostic impact of the conventional STS score on 1-year mortality after TAVR differ between Asian and non-Asian populations?
Does the prognostic impact of the conventional STS score on 1-year mortality after TAVR differ between Asian and non-Asian populations?
The prognostic value of the conventional STS score for predicting 1-year mortality after TAVR differs significantly between Asian and non-Asian populations.
Answers are grounded in this paper and cite their sources.
STS score may miscalibrate risk differently in Asian TAVR patients; leaves open validation of ethnicity-specific models.
Background: Interracial differences in the distribution and prognostic value of conventional Society of Thoracic Surgeons (STS) score on long-term mortality after transcatheter aortic valve replacement (TAVR) are uncertain. Objectives: This study aims to compare the impact of STS scores on clinical outcomes at 1-year after TAVR between Asian and non-Asian populations. Methods: We used the Trans-Pacific TAVR (TP-TAVR) registry, a multinational multicenter, observational registry involving patients undergoing TAVR at 2 major centers in the United States and 1 major center in Korea. Patients were classified into 3 groups (low, intermediate, and high-risk) according to the STS score and compared between STS risk groups and race. The primary outcome was all-cause mortality at 1-year. Conclusions: In this multiracial registry of patients with severe aortic stenosis who underwent TAVR, we identified a differential proportion and prognostic impact of STS score on 1-year mortality between Asian and non-Asian patients (TP-TAVR [Transpacific TAVR Registry]; NCT03826264).
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: